Summit Financial’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.51M | Buy |
32,719
+3,224
| +11% | +$346K | 0.08% | 210 |
|
|
2025
Q1 | $2.98M | Buy |
29,495
+12
| +0% | +$1.21K | 0.08% | 207 |
|
|
2024
Q4 | $2.63M | Buy |
29,483
+3,428
| +13% | +$306K | 0.09% | 179 |
|
|
2024
Q3 | $2.18M | Buy |
26,055
+601
| +2% | +$50.4K | 0.09% | 172 |
|
|
2024
Q2 | $1.96M | Buy |
25,454
+9,823
| +63% | +$756K | 0.09% | 158 |
|
|
2024
Q1 | $1.07M | Sell |
15,631
-138
| -0.9% | -$9.45K | 0.06% | 178 |
|
|
2023
Q4 | $912K | Buy |
15,769
+445
| +3% | +$25.7K | 0.06% | 179 |
|
|
2023
Q3 | $809K | Sell |
15,324
-149
| -1% | -$7.87K | 0.06% | 184 |
|
|
2023
Q2 | $837K | Sell |
15,473
-403
| -3% | -$21.8K | 0.06% | 172 |
|
|
2023
Q1 | $794K | Buy |
15,876
+117
| +0.7% | +$5.85K | 0.07% | 136 |
|
|
2022
Q4 | $729K | Buy |
15,759
+1,451
| +10% | +$67.1K | 0.07% | 142 |
|
|
2022
Q3 | $554K | Buy |
14,308
+2,331
| +19% | +$90.3K | 0.05% | 159 |
|
|
2022
Q2 | $446K | Buy |
11,977
+536
| +5% | +$20K | 0.04% | 162 |
|
|
2022
Q1 | $507K | Buy |
11,441
+2,224
| +24% | +$98.5K | 0.04% | 174 |
|
|
2021
Q4 | $392K | Buy |
9,217
+1,552
| +20% | +$65.9K | 0.03% | 188 |
|
|
2021
Q3 | $333K | Buy |
+7,665
| New | +$333K | 0.03% | 178 |
|